| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $483.0M | $986.4M | $787.0M |
| YoY Revenue Growth % | -51.0% | +25.3% | — |
| Gross Profit | $155.8M | $438.9M | — |
| Gross Margin % | 32.3% | 44.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $83.3M | $364.1M | $184.7M |
| Operating Margin % | 17.3% | 36.9% | 23.5% |
| Net Income (GAAP) | $474.4M | $359.1M | $173.5M |
| EBITDA (Normalized) | $100.7M | $399.6M | $213.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $256.7M | $261.6M | $298.4M |
| Capital Expenditures (CapEx) | $21.7M | $44.4M | $35.4M |
| Free Cash Flow (FCF) | $234.9M | $217.2M | $263.0M |
| FCF Margin % | 48.6% | 22.0% | 33.4% |
| Return on Invested Capital (ROIC %) | 3.0% | 11.5% | 7.7% |
| Cash & Short-Term Equivalents | $842.9M | $303.1M | — |
| Total Debt (Short + Long Term) | $845.3M | $1.04B | $733.0M |
| Total Stockholders' Equity | $2.21B | $1.77B | $1.50B |